Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dalloz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Revista Espanola De Cardiologia|June 20, 2001
[Genetically modified animal models in cardiovascular research]F Dalloz, H Osinska, J Robbins
Journal of Molecular and Cellular Cardiology|January 3, 2001
Manipulating the contractile apparatus: genetically defined animal models of cardiovascular diseaseF Dalloz, H Osinska, J Robbins
Fundamental & Clinical Pharmacology|October 16, 1999
Antioxidant properties of aminoguanidineC Courderot-Masuyer, F Dalloz, V Maupoil, et al.
Molecular and Cellular Biochemistry|February 5, 1998
In vitro studies of interactions of NO. donor drugs with superoxide and hydroxyl radicalsF Dalloz, V Maupoil, S Lecour, et al.
Fundamental & Clinical Pharmacology|October 30, 1998
Studies by electron paramagnetic resonance of the importance of iron in the hydroxyl scavenging properties of ascorbic acid in plasma: effects of iron chelatorsM Benderitter, V Maupoil, C Vergely, et al.
Free Radical Biology & Medicine|May 8, 1999
Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the ratF Dalloz, P Maingon, Y Cottin, et al.
Clinical Cardiology|October 2, 1998
Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiographyY Cottin, C Touzery, F Dalloz, et al.
Molecular and Cellular Biochemistry|January 8, 1999
Direct evidence of caeruloplasmin antioxidant propertiesR L Atanasiu, D Stea, M A Mateescu, et al.
Fundamental & Clinical Pharmacology|May 5, 1998
Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarctionY Cottin, J M Doise, V Maupoil, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revista Espanola De Cardiologia|June 20, 2001
[Genetically modified animal models in cardiovascular research]F Dalloz, H Osinska, J Robbins
Journal of Molecular and Cellular Cardiology|January 3, 2001
Manipulating the contractile apparatus: genetically defined animal models of cardiovascular diseaseF Dalloz, H Osinska, J Robbins
Fundamental & Clinical Pharmacology|October 16, 1999
Antioxidant properties of aminoguanidineC Courderot-Masuyer, F Dalloz, V Maupoil, et al.
Molecular and Cellular Biochemistry|February 5, 1998
In vitro studies of interactions of NO. donor drugs with superoxide and hydroxyl radicalsF Dalloz, V Maupoil, S Lecour, et al.
Fundamental & Clinical Pharmacology|October 30, 1998
Studies by electron paramagnetic resonance of the importance of iron in the hydroxyl scavenging properties of ascorbic acid in plasma: effects of iron chelatorsM Benderitter, V Maupoil, C Vergely, et al.
Free Radical Biology & Medicine|May 8, 1999
Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the ratF Dalloz, P Maingon, Y Cottin, et al.
Clinical Cardiology|October 2, 1998
Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiographyY Cottin, C Touzery, F Dalloz, et al.
Molecular and Cellular Biochemistry|January 8, 1999
Direct evidence of caeruloplasmin antioxidant propertiesR L Atanasiu, D Stea, M A Mateescu, et al.
Fundamental & Clinical Pharmacology|May 5, 1998
Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarctionY Cottin, J M Doise, V Maupoil, et al.
Pageof 1